Fig. 3
From: Prognosis prediction based on methionine metabolism genes signature in gliomas
Prognostic model evaluation and validation in validation sets. (A-C) Time-dependent ROC curves for the signature of seven methionine metabolism genes in the cohorts (A) CGGA-325, (B) CGGA-mRNA array, and (C) CGGA-693. (D–F) KM curve of the prognosis signature in the (D) CGGA-325, (E) CGGA- mRNA array and (F) CGGA-693 cohorts (log‐rank test). (G-I) The riskscore, survival status and expression distribution of a signature based on seven methionine metabolism genes for glioma patients in the cohorts (G) CGGA-325, (H) CGGA-mRNA array, and (I) CGGA-693